• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

结核分枝杆菌对利福平和乙胺丁醇的耐药性:一项临床调查。

Mycobacterium tuberculosis resistance to rifampicin and ethambutol: a clinical survey.

作者信息

Macdonald J B

出版信息

Thorax. 1977 Feb;32(1):1-4. doi: 10.1136/thx.32.1.1.

DOI:10.1136/thx.32.1.1
PMID:402706
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC470516/
Abstract

Ninety-seven cultures of Myco, tuberculosis referred to the Tuberculosis Reference Laboratory, Cardiff during 1972-73 and found to be resistant to rifampicin or ethambutol were studied. Resistance to each drug appeared equally common. Few lower grades of rifampicin resistance occurred, cultures tending to be either fully sensitive or highly resistant. Intermediate grades of ethambutol resistance, however, were common, and a majority of highly resistant cultures were preceded by cultures showing lower grades of resistance. Case-notes were obtained on 84 patients (87%) and revealed no cases of primary resistance. In the three years since first developing resistance 36% of patients died: in the majority tuberculosis was a major cause of death. Half the patients had been prescribed unsatisfactory drug regimens containing rifampicin or ethambutol by their physicians, and only a small minority were considered to have co-operated well. One-third had discharged themselves from hospital against medical advice and only 21% attended clinics regularly. These two factors probably accounted for the development of resistance in most cases.

摘要

1972 - 1973年期间,97株结核分枝杆菌培养物被送往加的夫结核病参考实验室,结果发现它们对利福平或乙胺丁醇耐药,并对其进行了研究。对每种药物的耐药情况似乎同样常见。利福平低等级耐药情况较少,培养物往往要么完全敏感,要么高度耐药。然而,乙胺丁醇中等程度耐药情况很常见,大多数高度耐药培养物之前都有显示较低等级耐药的培养物。对84名患者(87%)进行了病例记录,未发现原发性耐药病例。自首次出现耐药后的三年里,36%的患者死亡:大多数情况下,结核病是主要死因。一半患者的医生曾为其开出含利福平或乙胺丁醇的不理想药物治疗方案,只有一小部分患者被认为配合良好。三分之一的患者自行出院,违背了医嘱,只有21%的患者定期到诊所就诊。这两个因素可能是大多数病例产生耐药性的原因。

相似文献

1
Mycobacterium tuberculosis resistance to rifampicin and ethambutol: a clinical survey.结核分枝杆菌对利福平和乙胺丁醇的耐药性:一项临床调查。
Thorax. 1977 Feb;32(1):1-4. doi: 10.1136/thx.32.1.1.
2
[Activity of the second-line preparations, ethambutol and rifampin, in experimental tuberculosis caused by Mycobacterium tuberculosis highly resistant to basic tuberculostatics].[二线制剂乙胺丁醇和利福平在对基本抗结核药高度耐药的结核分枝杆菌所致实验性结核病中的活性]
Probl Tuberk. 1973;51(12):60-4.
3
[Survival of tuberculous bacilli in combined treatments including rifampicin].[结核杆菌在含利福平联合治疗中的存活情况]
Rev Tuberc Pneumol (Paris). 1970 Apr-May;34(3):429-33.
4
Primary and acquired drug resistance in Mycobacterium tuberculosis strains in western region of Libyan Arab Jamahiriya.阿拉伯利比亚民众国西部地区结核分枝杆菌菌株的原发性和获得性耐药性
Trop Geogr Med. 1989 Oct;41(4):304-8.
5
Drug resistance in tuberculosis in Delhi: a 2 year profile (2001--2002).德里结核病的耐药性:两年概况(2001 - 2002年)
J Commun Dis. 2003 Jun;35(2):74-81.
6
[Clinical significance of drug resistance of tuberculosis mycobacteria and L-forms].[结核分枝杆菌及L型耐药性的临床意义]
Probl Tuberk. 1991(12):27-8.
7
Long-term results with rifampicin together with ethambutol and-or other drugs in the treatment of tuberculosis with cultures resistant to the standard drugs.利福平联合乙胺丁醇及/或其他药物治疗对标准药物耐药的结核病的长期疗效。
Respiration. 1971;28:Suppl:91-6. doi: 10.1159/000194965.
8
[Dynamics of rifampicin and ethambutol resistance of strains of Koch bacilli isolated from patients with pulmonary tuberculosis 1973-1981].
Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Pneumoftiziol. 1982 Oct-Dec;31(4):315-20.
9
Rifampicin and ethambutol in the treatment of drug resistant and far advanced pulmonary tuberculosis (with a note on capreomycin).利福平与乙胺丁醇治疗耐药及晚期肺结核(附对卷曲霉素的说明)
J Ir Med Assoc. 1970 Mar;63(393):82-5.
10
[Experimental in-vitro and in-vivo studies of the antibacterial effect of rifampicin and ethambutol].
G Ital Chemioter. 1972 Jan-Jun;19(2):7-10.

引用本文的文献

1
Shortfalls identified in the management of tuberculosis for Mozambican patients obtaining health care services in Malawi.在马拉维接受医疗服务的莫桑比克结核病患者的管理中发现的不足之处。
Malawi Med J. 2003 Jun;15(2):61-2. doi: 10.4314/mmj.v15i2.10779.
2
Low incidence of rifampicin-resistant tubercle bacilli.耐利福平结核杆菌的低发生率。
Thorax. 1982 Jul;37(7):526-7. doi: 10.1136/thx.37.7.526.
3
Trends in the epidemiology of tuberculosis--a physician's view.结核病流行病学趋势——一位医生的视角
J Clin Pathol. 1983 Oct;36(10):1087-90. doi: 10.1136/jcp.36.10.1087.

本文引用的文献

1
Test for detection of ethambutol in urine.尿液中乙胺丁醇的检测试验。
Can J Public Health. 1971 May-Jun;62(3):251-2.
2
Simple procedures for checking rifampin in urine.尿液中利福平检测的简易程序。
Am Rev Respir Dis. 1969 Nov;100(5):738-9. doi: 10.1164/arrd.1969.100.5.738.
3
The pattern of resistance development to rifampicin in Mycobacterium tuberculosis.结核分枝杆菌对利福平耐药性的发展模式。
Tubercle. 1972 Jun;53(2):111-7. doi: 10.1016/0041-3879(72)90027-x.
4
Improvement of drg-sensitivity tests on tubercle bacilli.
Tubercle. 1970 Mar;51(1):68-75. doi: 10.1016/0041-3879(70)90129-7.